Semantic Recognition Task (SRT) in Alzheimer Disease

Sponsor
Istanbul University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05711888
Collaborator
(none)
80
1
1
1.2
67.6

Study Details

Study Description

Brief Summary

The goal of this study is to observe the outcomes of a semantic recognition task in Alzheimer Disease and discuss what this might add to clinical practice.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Semantic Recognition Procedure
N/A

Detailed Description

In classical memory testing procedures, the outcomes of recognition task is related to hippocampal memory deficits knowing that the recognition task is not purely temporal lobe activity. The aim of this study is to propose a recognition task more specific to temporal lobe activity.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Semantic recognition task outcomes are observed in people diagnosed with Alzheimer's disease with Non-Alzheimer population.Semantic recognition task outcomes are observed in people diagnosed with Alzheimer's disease with Non-Alzheimer population.
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
A Sensitive Measurement Proposal in Alzheimer's Disease: Semantic Recognition Task
Actual Study Start Date :
Dec 21, 2022
Actual Primary Completion Date :
Jan 20, 2023
Anticipated Study Completion Date :
Jan 26, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Semantic information in Alzheimer Disease

To observe the semantic information processing in early stages of Alzheimer Disease is the main aim of the study. A paper-pencil neuropsychological assessment battery will be used. For memory testing FCSRT (free and cued selective reminding test) will be used. The patients are going to be assessed while in clinical diagnosis routine.

Behavioral: Semantic Recognition Procedure
A semantic recognition task is going to be added to administrated FCSRT procedure after immediate and delayed recall phases.

Outcome Measures

Primary Outcome Measures

  1. Semantic Recognition Task [1 day]

    The number of correct answers will be observed just after the short-term learning procedure and just after the delayed recall procedure among people with positive biomarker compared to those with negative biomarker to Alzheimer Disease.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • to have biomarker analysis for Alzheimer disease (positive or negative).
Exclusion Criteria:
  • illiteracy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jbid Dursun Uncu Beşiktaş İstanbul Turkey 34340

Sponsors and Collaborators

  • Istanbul University

Investigators

  • Study Director: İ. Hakan Gürvit, Prof. MD., Istanbul University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jbid DURSUN UNCU, PhD Student, Istanbul University
ClinicalTrials.gov Identifier:
NCT05711888
Other Study ID Numbers:
  • E-29624016-050.99-1484553
First Posted:
Feb 3, 2023
Last Update Posted:
Feb 3, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jbid DURSUN UNCU, PhD Student, Istanbul University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 3, 2023